Boulder Becomes Hub for Colorado’s First Three Psilocybin Healing Centers
Boulder has cemented itself as the epicenter of Colorado’s emerging psilocybin therapy industry. Three healing centers now offer supervised psychedelic mushroom sessions in the city. These facilities mark a major milestone in the state’s natural medicine program.
Looking for treatment? Find ketamine clinics closest to you as well as other psychedelic therapies in your area.
Key Takeaways
| Topic | Details |
|---|---|
| Centers That Opened | Three facilities: Happy Rebel Healing, Chariot, Psychedelic Growth |
| Session Costs | $1,500 to $3,400 per session |
| State Status | Colorado is only the second state after Oregon to license psilocybin centers |
| Federal Status | Psilocybin remains a Schedule I controlled substance |
| Licensing Timeline | Applications opened December 2024; first centers licensed in 2025 |
Do you work in the ketamine industry? Save thousands on overhead and other fees by joining the first GPO for ketamine clinics and practitioners. There’s no cost to join and zero obligations. Sign up here!
Why Boulder Led the Way
The city’s early adoption comes as no surprise. Naropa University once housed a Center for Psychedelic Studies and offered an undergraduate minor in the field. This academic foundation helped create a community ready to embrace regulated psychedelic therapy.
Coloradans voted to legalize regulated psilocybin access in 2022 through Proposition 122. The state began accepting license applications in late 2024. Boulder moved quickly to establish supportive zoning rules for these new facilities.
New:Â Interested in Being Part of a Psychedelics-Focused Clinical Trial? Sign Up Here
The Cost Challenge
Affordability remains a significant hurdle. Happy Rebel Healing charges approximately $2,800 for a session. Chariot offers sessions ranging from $1,500 to $3,000. Psychedelic Growth comes in at $3,400 per session.
These prices reflect challenges unique to the industry. Psilocybin’s federal Schedule I status creates banking complications. Credit card processors and financial institutions remain hesitant to work with these businesses. Similar issues plagued Oregon’s program, the only other state allowing psychedelic therapy.
What Comes Next
The federal government has shown increasing openness to psychedelic medicine. The FDA has designated psilocybin a breakthrough therapy for treatment resistant depression. Clinical trials continue to show promise for conditions including anxiety, PTSD, and substance use disorder.
For Coloradans seeking alternatives to traditional mental health treatment, Boulder’s healing centers offer a new path. The coming months will reveal whether other Colorado communities follow Boulder’s lead or impose stricter regulations on this emerging field.
